Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples